Clinical Trial Update: Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating apatinib as maintenance therapy after etoposide/cisplatin in extensive-stage small cell lung cancer; current status is not dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Third Military Medical University | Conditions: Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN